Blog / Archives
2019 J.P.Morgan Conference Update: Healthcare Stocks Rally with Break-Outs…Updates
Update 1/14 After close: Biopharmas on the weak side from drug pricing politics. Both parties focused on pharmaceutical drug prices. IBB at $107.17 down 1.69% ; XBI at $80.12 down 2.29%. Red screen...
2019 J.P.Morgan Healthcare Notes #1 Panel: Reinventing the Disease Continuum Through Precision Health…Update
Update-1...1/21/19 Liquid Biopsy I attended a Panel Session on Cancer Liquid Biopsy and although progress is being made on molecular diagnostics there are no newsworthy breakthroughs nor actual data...
Big Biopharma Bounce off Bottom: Mid Caps…Updates
1/7/19 ...After Close: Most Mid-Caps held gains but check AH trading Selected Winners today: AGIO 8.7%, ALNY 8.75%, ARRY 8.85%, BLUE 6.67%, BPMC 14.1%, NKTR 7.83%, SGEN 5.68%, ICPT 7.28%, XBI 5.97%...
Large Cap Biopharmaceutical Performance 2018…Updates BMY CELG, XBI
1/7/19 After Close: Both BMY and CELG held today up over 3%. ==== Stay tuned Next Week for Updates from the J.P.Morgan Healthcare Conference 1/5/19 Friday's broad-based biopharmaceutical rally...
Free Falling Biotech Stocks Hit New 52 Week Lows…Updates 12/29
Update: 12/29/18 Biotech Stocks Halt Slide: IBB down 0.34% to $94.84 and up 4.7% for the week, XBI up 0.73% to $70.09 and up 5.6% for the week. XLV up 3.5% for the week to $85.25.Volatile market...
Bull Case for Biotech Remains Elusive-Trade Carefully…Update after FED Meeting
Update-2 After close: Market Collapses After FED Meeting-Bear Market WE all knew that the biotech sector likes looser monetary policy but this sell-off is ridiculous. The IBB is now at May...
Trade Fears Derail Biotech Rally in a Jittery Market…Updates
Update -4 After Close 12/7/18 Market Performance for the Week XBI down 7.8%, IBB down 6.6%, XLV down 5.2%, QQQ down 5.11%. Futures not looking good at 12:40a EST, NAZ down 0.82%. Global Growth...
Trading the Biotech Bottom in 2018 in an Ambivalent Market…Updates ASH TSRO XBI
Update-2 December 3 ...Our Top Pick TSRO is up 58% on GSK Buyout We recommended Tesaro (TSRO) at $34 and it paid off today with a ~$5.1B buyout by GlaxoSmith Kline! Year End Rally Intact with XBI up...
Trade the Seasonal Rally in Biotech Off the 2018 Bottom…Updates AMGN TSRO XBI
Update for the Week: Trying to Find the Bottom-Choppy Action But Tradeable XBI holds above $74.62 bottom up 1.3% for the week but can't hold today's gains. AMGN flat for the week at $193 but can't...
2018 Biopharmaceutical Performance-Large Caps: Big winners were Merck and Vertex…Update- Rally Underway
11/16...TSRO Alert at $35, Up 32%, Company is for Sale 11/15p After Close...Traders: Rally is intact but needs another green day to confirm. Big mid-cap 4% movers today: AGIO ARNA (up 21.6%) ARRY...